<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:blogger='http://schemas.google.com/blogger/2008' xmlns:georss='http://www.georss.org/georss' xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-3368600154463886900</id><updated>2024-09-08T21:52:16.025+05:30</updated><category term="new drugs"/><category term="clinical trials"/><category term="Cardiovascular Risk"/><category term="Diabetes"/><category term="Pharmacology"/><category term="lifestyle"/><category term="FDA"/><category term="drugs"/><category term="medical education"/><category term="teaching"/><category term="cardiovascular disease"/><category term="Antibiotic resistance"/><category term="Antimicrobial activity"/><category term="Search"/><category term="antimicrobial"/><category term="drug information"/><category term="hypertension"/><category term="diet"/><category term="research"/><category term="Drug discovery and development"/><category term="clinical research"/><category term="research  methodology"/><category term="Cancer"/><category term="Nigella sativa"/><category term="Pharma news"/><category term="Pharmaweb links"/><category term="clinical pharmacology"/><category term="Adverse Drug Reaction"/><category term="academic research"/><category term="drug resources"/><category term="infections"/><category term="obesity"/><category term="pharmacology resources"/><category term="software"/><category term="students"/><category term="teachin resources"/><category term="Black cumin"/><category term="CAL"/><category term="Pharma industry"/><category term="Pharma website"/><category term="RUD"/><category term="RUM"/><category term="cholesterol"/><category term="journals"/><category term="ACE inhibitor"/><category term="ADR"/><category term="Black seed"/><category term="CAM"/><category term="Mediterranean diet"/><category term="Methicillin-resistant Staphylococcus aureus"/><category term="Nanotechnology"/><category term="approval"/><category term="books"/><category term="epilepsy"/><category term="experiments"/><category term="learning"/><category term="pain"/><category term="papers"/><category term="screening"/><category term="statins"/><category term="teaching methods"/><category term="viral infections"/><category term="ARB"/><category term="Angiogenesis"/><category term="Anticancer"/><category term="COX 2 inhibition"/><category term="Drug Prescribing Pattern"/><category term="Fish"/><category term="HIV"/><category term="Incretins"/><category term="Nanomedicine"/><category term="Nanoparticle"/><category term="Staphylococci"/><category term="Staphylococcus"/><category term="antioxidants"/><category term="blood sugar"/><category term="breast cancer"/><category term="cephalosporin"/><category term="depression"/><category term="ebooks"/><category term="fats"/><category term="generic name"/><category term="influenza"/><category term="islamic"/><category term="medical books"/><category term="online access"/><category term="prescription analysis"/><category term="prescription audit"/><category term="simulation"/><category term="sleep"/><category term="AIDS"/><category term="Adverse effect"/><category term="Antidepressant"/><category term="Antiretroviral"/><category term="Bacillus"/><category term="CRP"/><category term="DPP-IV"/><category term="Essential oil"/><category term="ExPharm"/><category term="Gene therapy"/><category term="Germination"/><category term="Gram Positive Bacteria"/><category term="Herbal drugs"/><category term="JUPITER"/><category term="LDL"/><category term="MCI"/><category term="Nimesulide"/><category term="ReMe"/><category term="Rimonibant"/><category term="Surgical Wards"/><category term="Vitamin D"/><category term="WHO"/><category term="Web 2.0"/><category term="animal models"/><category term="anticonvulsant"/><category term="antidiabetics"/><category term="antiepileptic"/><category term="banned drugs"/><category term="cannabinoid receptors"/><category term="circumcision"/><category term="databases"/><category term="diuretic"/><category term="downloads"/><category term="drug targets"/><category term="epidermal growth factor receptor"/><category term="exercise"/><category term="free books"/><category term="glucagon-like peptide-1"/><category term="history"/><category term="kalonji"/><category term="metabolic syndrome"/><category term="microdosing"/><category term="motivation"/><category term="nanocrystalline silver"/><category term="olive oil"/><category term="pharma"/><category term="presentations"/><category term="psychology"/><category term="rosuvastatin"/><category term="scientist"/><category term="stem cells"/><category term="swine influenza"/><category term="vaccine"/><category term="ADHD"/><category term="Accupuncture"/><category term="Acute Angle closureGlaucoma"/><category term="Agomelatine"/><category term="Alzheimer&#39;s"/><category term="Amlodipine"/><category term="Analgesic activity"/><category term="Androgens"/><category term="Angina"/><category term="Anti-inflammatory Activity"/><category term="Antibiotic Prophylaxis"/><category term="BMI"/><category term="Bioethics"/><category term="Bromocriptine"/><category term="C1 inhibitor"/><category term="CDC"/><category term="CVS"/><category term="Clinical isolates"/><category term="Coagulase negative staphylococci"/><category term="Cochrane review"/><category term="CrossRef"/><category term="DARPins"/><category term="DNA methylation"/><category term="DPP-4 inhibitors"/><category term="Dapoxetine"/><category term="Darwin"/><category term="Dental"/><category term="Drug Induced Glaucoma"/><category term="EGF"/><category term="EGFR antagonist"/><category term="EML"/><category term="Endorphins"/><category term="Enterococcus"/><category term="Escitalopram"/><category term="Exenatide"/><category term="Flavoxate"/><category term="GCP"/><category term="GERD"/><category term="GLP-1 receptor agonists"/><category term="Glaucoma"/><category term="Glycemic control"/><category term="GnRH"/><category term="HDRS score"/><category term="HPV"/><category term="HSV"/><category term="Hadith"/><category term="Heart"/><category term="Hepatoprotective"/><category term="Herbal drug Technology"/><category term="Hyperthyroidism"/><category term="IBS"/><category term="ISI"/><category term="Leucopenia"/><category term="MADRS score"/><category term="NIH"/><category term="NSAIDs"/><category term="Nanorobots"/><category term="Nuts"/><category term="OAB"/><category term="PLoS ONE"/><category term="Parenting"/><category term="Pitavastatin"/><category term="Pseudomonas aeruginosa"/><category term="Pyrexia"/><category term="Quran"/><category term="Rational Use of Medicines"/><category term="Renal disease"/><category term="SSRI"/><category term="STD"/><category term="Scopus"/><category term="Sitagliptin"/><category term="Staphylococcus epidermidis"/><category term="Streptococcus"/><category term="Surgery"/><category term="Surgical Prophylaxis"/><category term="Thyrotoxicosis"/><category term="Translational pharmacology"/><category term="Type 2 Diabetes Mellitus"/><category term="Women&#39;s Health"/><category term="ZEFTERA"/><category term="adolescents"/><category term="amphotericin B"/><category term="amyloid beta"/><category term="antifungal"/><category term="antiobesity"/><category term="antithrombin"/><category term="anxiety"/><category term="arthritis"/><category term="authors"/><category term="biobar"/><category term="bioinformatics"/><category term="biologics"/><category term="brain"/><category term="chemokine receptor inhibitor"/><category term="chemotherapy"/><category term="children"/><category term="circardian rythm"/><category term="citations"/><category term="contraceptive"/><category term="cooking"/><category term="courseware"/><category term="decision making"/><category term="early fetal demise"/><category term="evolution"/><category term="fibrinogen"/><category term="fruits"/><category term="genetics"/><category term="globalization"/><category term="heredity"/><category term="histone"/><category term="hits"/><category term="immunotherapy"/><category term="impact factor"/><category term="insomnia"/><category term="insulin"/><category term="intelligence"/><category term="intelligent design"/><category term="ion channels"/><category term="lead"/><category term="learning styles"/><category term="malpractice"/><category term="mammography"/><category term="men&#39;s health"/><category term="metoprolol"/><category term="migraine"/><category term="misoprostol"/><category term="monoclonal antibodies"/><category term="nosocomial infections"/><category term="opioid receptor antagonist"/><category term="oral route"/><category term="orlistat"/><category term="oseltamivir"/><category term="osteoporosis"/><category term="outsourcing"/><category term="pandemic"/><category term="pharmacoepigenetics"/><category term="pharmacokinetics"/><category term="phase 0"/><category term="polio"/><category term="polypill"/><category term="prediabetes"/><category term="premature ejaculation"/><category term="s"/><category term="seizures"/><category term="sexually transmitted diseases"/><category term="siRNS"/><category term="smoking"/><category term="sodium"/><category term="stress"/><category term="subconcious"/><category term="sublingual route"/><category term="teenagers"/><category term="thrombopoietin receptor agonist"/><category term="transmission"/><category term="triamcinolone"/><category term="vinegar"/><category term="wiki"/><category term="xenografts"/><title type='text'>Biomedical research and Education</title><subtitle type='html'></subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default?redirect=false'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default?start-index=26&amp;max-results=25&amp;redirect=false'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>194</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-3398980314797464219</id><published>2015-08-12T23:03:00.001+05:30</published><updated>2015-08-12T23:03:33.701+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Agomelatine"/><category scheme="http://www.blogger.com/atom/ns#" term="Antidepressant"/><category scheme="http://www.blogger.com/atom/ns#" term="blood sugar"/><category scheme="http://www.blogger.com/atom/ns#" term="depression"/><category scheme="http://www.blogger.com/atom/ns#" term="Escitalopram"/><category scheme="http://www.blogger.com/atom/ns#" term="Glycemic control"/><category scheme="http://www.blogger.com/atom/ns#" term="HDRS score"/><category scheme="http://www.blogger.com/atom/ns#" term="MADRS score"/><category scheme="http://www.blogger.com/atom/ns#" term="Type 2 Diabetes Mellitus"/><title type='text'>Comparative Effect of Agomelatine versus Escitalopram on Glycemic Control and Symptoms of Depression in Patients with Type 2 Diabetes Mellitus and Depression</title><summary type="text">

Kumar K, Salman MT, Shukla V, Ahmad A, Verma V K, Rizvi D A and Kohli A: Comparative Effect of Agomelatine versus Escitalopram on Glycemic Control and Symptoms of Depression in Patients with Type 2 Diabetes Mellitus and Depression). Int J Pharm Sci Res 2015; 6(10): 1000-06.doi: 10.13040/IJPSR.0975-8232.6(10).1000-06.



Introduction: A bidirectional relationship exists between type 2 diabetes </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/3398980314797464219/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2015/08/comparative-effect-of-agomelatine.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/3398980314797464219'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/3398980314797464219'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2015/08/comparative-effect-of-agomelatine.html' title='Comparative Effect of Agomelatine versus Escitalopram on Glycemic Control and Symptoms of Depression in Patients with Type 2 Diabetes Mellitus and Depression'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-1690886237689710470</id><published>2015-08-12T17:23:00.006+05:30</published><updated>2015-08-12T17:28:22.565+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="animal models"/><category scheme="http://www.blogger.com/atom/ns#" term="Antidepressant"/><category scheme="http://www.blogger.com/atom/ns#" term="antiepileptic"/><category scheme="http://www.blogger.com/atom/ns#" term="anxiety"/><category scheme="http://www.blogger.com/atom/ns#" term="Black cumin"/><category scheme="http://www.blogger.com/atom/ns#" term="Black seed"/><category scheme="http://www.blogger.com/atom/ns#" term="CAM"/><category scheme="http://www.blogger.com/atom/ns#" term="depression"/><category scheme="http://www.blogger.com/atom/ns#" term="epilepsy"/><category scheme="http://www.blogger.com/atom/ns#" term="Germination"/><category scheme="http://www.blogger.com/atom/ns#" term="Herbal drugs"/><category scheme="http://www.blogger.com/atom/ns#" term="islamic"/><category scheme="http://www.blogger.com/atom/ns#" term="kalonji"/><category scheme="http://www.blogger.com/atom/ns#" term="Nigella sativa"/><title type='text'>Neuroprotective effects of Nigella sativa extracts during germination on central nervous system</title><summary type="text">

Islam MH, Ahmad IZ, Salman MT. Neuroprotective effectsof Nigella sativa extracts during germination on central nervous system. Phcog
Mag 2015;11:182-9.



Background: Nigella sativa Linn. which has many acclaimed medicinal properties is an indigenous
herbaceous plant and belongs to the Ranunculaceae family, which grows in countries bordering
the Mediterranean Sea, Pakistan and India. Objective:</summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/1690886237689710470/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2015/08/neuroprotective-effects-of-nigella.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/1690886237689710470'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/1690886237689710470'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2015/08/neuroprotective-effects-of-nigella.html' title='Neuroprotective effects of Nigella sativa extracts during germination on central nervous system'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-5265158647041504402</id><published>2015-08-10T15:57:00.002+05:30</published><updated>2015-08-10T16:06:06.099+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Antibiotic Prophylaxis"/><category scheme="http://www.blogger.com/atom/ns#" term="Antibiotic resistance"/><category scheme="http://www.blogger.com/atom/ns#" term="cephalosporin"/><category scheme="http://www.blogger.com/atom/ns#" term="infections"/><category scheme="http://www.blogger.com/atom/ns#" term="prescription audit"/><category scheme="http://www.blogger.com/atom/ns#" term="Rational Use of Medicines"/><category scheme="http://www.blogger.com/atom/ns#" term="Surgery"/><category scheme="http://www.blogger.com/atom/ns#" term="Surgical Prophylaxis"/><category scheme="http://www.blogger.com/atom/ns#" term="Surgical Wards"/><title type='text'>Presurgical Antibiotic Prophylaxis Pattern In An Indian Tertiary Care Teaching Hospital</title><summary type="text">
Authors: Rupinder Kaur, Mohd Tariq Salman, Narendra K. Gupta, Uma Gupta, Ali Ahmad, Vinod K. Verma


The present study was performed to study the antibiotic prophylaxis pattern in patients admitted in Surgery and Obstetrics and Gynaecology wards of a Tertiary Care Teaching hospital in North India. It was an observational, non interventional and analytical study used to evaluate the patients </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/5265158647041504402/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2015/08/presurgical-antibiotic-prophylaxis.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/5265158647041504402'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/5265158647041504402'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2015/08/presurgical-antibiotic-prophylaxis.html' title='Presurgical Antibiotic Prophylaxis Pattern In An Indian Tertiary Care Teaching Hospital'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-9149605276117810612</id><published>2015-08-08T00:04:00.001+05:30</published><updated>2015-08-08T00:04:18.628+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="ADR"/><category scheme="http://www.blogger.com/atom/ns#" term="Adverse Drug Reaction"/><category scheme="http://www.blogger.com/atom/ns#" term="Adverse effect"/><category scheme="http://www.blogger.com/atom/ns#" term="clinical pharmacology"/><category scheme="http://www.blogger.com/atom/ns#" term="Hyperthyroidism"/><category scheme="http://www.blogger.com/atom/ns#" term="Leucopenia"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharmacology"/><category scheme="http://www.blogger.com/atom/ns#" term="Pyrexia"/><category scheme="http://www.blogger.com/atom/ns#" term="Thyrotoxicosis"/><title type='text'>Atypical Thyrotoxicosis Relapse after Carbimazole Discontinuation: A Case Report with Pharmacological View</title><summary type="text">
authors: Sharique Ahmad, Saeeda Wasim, Mohammed Tariq Salman, Mohammed Aqwam Siddiqui,
Nahid Shabnam, Pragya Khanna


A 15-year-old girl who presented with pyrexia of unknown origin of 3 month’s duration was evaluated and examined. She had two palpable axillary lymph nodes associated with mild hepatosplenomegaly and leukopenia (white blood cell count - 1700/cmm). Later was assessed for systemic </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/9149605276117810612/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2015/08/atypical-thyrotoxicosis-relapse-after.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/9149605276117810612'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/9149605276117810612'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2015/08/atypical-thyrotoxicosis-relapse-after.html' title='Atypical Thyrotoxicosis Relapse after Carbimazole Discontinuation: A Case Report with Pharmacological View'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total><georss:featurename>Era&amp;#39;s Lucknow Medical College and Hospital, Sarfarazganj, Lucknow, Uttar Pradesh 226003, India</georss:featurename><georss:point>26.8781629 80.872197599999936</georss:point><georss:box>-1.2186826000000011 39.563603599999936 54.9750084 122.18079159999994</georss:box></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-3004658773730987508</id><published>2015-08-07T23:49:00.000+05:30</published><updated>2015-08-10T15:49:37.911+05:30</updated><title type='text'>Challenges faced by males</title><summary type="text">




Challenging Toxic Masculinity

Author&amp;nbsp;Mel Rogers

As a group, men have certain advantages in society, the effects of which can be seen in a wide variety of ways— at all levels of government, for example, the overwhelming majority of positions are held by men, But while it&#39;s important to look at ways to redress these imbalances, it&#39;s also important to consider the ways in which this kind</summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/3004658773730987508/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2015/08/challenges-faced-by-males.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/3004658773730987508'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/3004658773730987508'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2015/08/challenges-faced-by-males.html' title='Challenges faced by males'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-7022868279710995266</id><published>2013-11-08T21:20:00.001+05:30</published><updated>2013-11-08T21:20:01.129+05:30</updated><title type='text'>Poor Quality of Sleep and its Relationship with Depression in First Year Medical Students. | . | Advances in Life Science and Technology</title><summary type="text">Poor Quality of Sleep and its Relationship with Depression in First Year Medical Students. | . | Advances in Life Science and Technology
Abdussalam , Mohammad Tariq Salman, Sushma Gupta, Mohit Trivedi, Mariam Farooqi

 Introduction: High incidence of depression has been reported in undergraduate medical students. Sleep disturbance has been associated with depressive symptoms and higher body mass </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/7022868279710995266/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2013/11/poor-quality-of-sleep-and-its.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/7022868279710995266'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/7022868279710995266'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2013/11/poor-quality-of-sleep-and-its.html' title='Poor Quality of Sleep and its Relationship with Depression in First Year Medical Students. | . | Advances in Life Science and Technology'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-5736878864981716216</id><published>2013-10-30T22:13:00.000+05:30</published><updated>2013-10-30T22:32:52.691+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="antioxidants"/><category scheme="http://www.blogger.com/atom/ns#" term="Black cumin"/><category scheme="http://www.blogger.com/atom/ns#" term="Black seed"/><category scheme="http://www.blogger.com/atom/ns#" term="Hepatoprotective"/><category scheme="http://www.blogger.com/atom/ns#" term="Herbal drugs"/><category scheme="http://www.blogger.com/atom/ns#" term="Nigella sativa"/><category scheme="http://www.blogger.com/atom/ns#" term="papers"/><title type='text'>In vivo Hepatoprotective Potential of Nigella sativa Extract Against Rifampicin Induced Sub-chronic Hepatotoxicity and Altered Redox Status</title><summary type="text">


In vivo Hepatoprotective Potential of Nigella sativa Extract Against Rifampicin Induced Sub-chronic Hepatotoxicity and Altered Redox Status

Journal of Biologically Active Products from Nature

Volume 2,&amp;nbsp;Issue 3, 2012



DOI:
10.1080/22311866.2012.10719124

Devendra Singh kushwaha,&amp;nbsp;Mohd Tariq Salmana*,&amp;nbsp;Hemant Kumar Singha,&amp;nbsp;Ali Ahmada&amp;nbsp;&amp;amp;&amp;nbsp;V.K. vermaa&amp;nbsp;

pages</summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/5736878864981716216/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2013/10/in-vivo-hepatoprotective-potential-of.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/5736878864981716216'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/5736878864981716216'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2013/10/in-vivo-hepatoprotective-potential-of.html' title='In vivo Hepatoprotective Potential of Nigella sativa Extract Against Rifampicin Induced Sub-chronic Hepatotoxicity and Altered Redox Status'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-4579067535178741993</id><published>2013-10-18T12:28:00.000+05:30</published><updated>2013-10-18T12:28:11.560+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Analgesic activity"/><category scheme="http://www.blogger.com/atom/ns#" term="Anti-inflammatory Activity"/><category scheme="http://www.blogger.com/atom/ns#" term="Black cumin"/><category scheme="http://www.blogger.com/atom/ns#" term="Black seed"/><category scheme="http://www.blogger.com/atom/ns#" term="CAM"/><category scheme="http://www.blogger.com/atom/ns#" term="COX 2 inhibition"/><category scheme="http://www.blogger.com/atom/ns#" term="experiments"/><category scheme="http://www.blogger.com/atom/ns#" term="Germination"/><category scheme="http://www.blogger.com/atom/ns#" term="Nigella sativa"/><category scheme="http://www.blogger.com/atom/ns#" term="NSAIDs"/><category scheme="http://www.blogger.com/atom/ns#" term="pain"/><category scheme="http://www.blogger.com/atom/ns#" term="papers"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharmacology"/><category scheme="http://www.blogger.com/atom/ns#" term="screening"/><title type='text'>Black cumin seeds possess analgesic and anti-inflammatory activity comparable to indomethacin.</title><summary type="text">
IN VIVO EVALUATION OF ANTI-INFLAMMATORY AND ANALGESIC ACTIVITIES OF NIGELLA SATIVA SEED DURING GERMINATION

MOHAMMAD HAYATUL ISLAM, IFFAT ZAREEN AHMAD AND MOHAMMAD TARIQ SALMAN

Objective: The medicinal values of Nigella sativa have been mentioned in ancient literature as useful in disorders of inflammation. The present study investigates the anti-inflammatory and analgesic activities of </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/4579067535178741993/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2013/10/black-cumin-seeds-possess-analgesic-and.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/4579067535178741993'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/4579067535178741993'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2013/10/black-cumin-seeds-possess-analgesic-and.html' title='Black cumin seeds possess analgesic and anti-inflammatory activity comparable to indomethacin.'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-5338304568932370535</id><published>2013-06-01T16:28:00.000+05:30</published><updated>2013-06-01T16:28:05.747+05:30</updated><title type='text'>Black Cumin seed (Nigella sativa, Kalonji) protects against Paracetamol induced hepatotoxicity</title><summary type="text">

Protective Effects of Ethanolic Extract of Nigella sativa Seed in Paracetamol Induced Acute Hepatotoxicity In vivo

D.S. Kushwah, M.T. Salman, P. Singh, V.K. Verma and A. Ahmad



Paracetamol overdose causes serious liver necrosis. Hepatoprotective activity of ethanolic extract of Nigella sativa in Paracetamol induced acute hepatotoxicity was investigated in rats. Fasted male Wistar rats were </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/5338304568932370535/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2013/06/black-cumin-seed-nigella-sativa-kalonji.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/5338304568932370535'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/5338304568932370535'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2013/06/black-cumin-seed-nigella-sativa-kalonji.html' title='Black Cumin seed (Nigella sativa, Kalonji) protects against Paracetamol induced hepatotoxicity'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-8886514720091883600</id><published>2013-02-21T07:30:00.002+05:30</published><updated>2013-02-21T07:30:30.052+05:30</updated><title type='text'>Recent new drug approvals</title><summary type="text">


1. Icosapent ethyl (Vascepa)


Indication:
Adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500mg/dL) hypertriglyceridemia.&amp;nbsp;
Pharmacology:
Icosapent ethyl is an ethyl ester of the omega-3 fatty acid eicosapentaenoic acid (EPA).
Studies suggest that eicosapentaenoic acid reduces hepatic very low-density lipoprotein triglycerides (VLDL-TG) synthesis and/or </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/8886514720091883600/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2013/02/recent-new-drug-approvals.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/8886514720091883600'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/8886514720091883600'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2013/02/recent-new-drug-approvals.html' title='Recent new drug approvals'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-6011918588146293793</id><published>2013-02-15T11:21:00.001+05:30</published><updated>2013-02-15T11:21:26.198+05:30</updated><title type='text'>Antibacterial activity of Nigella sativa seed in various  germination phases on clinical bacterial strains isolated  from human patients</title><summary type="text">

See full text of paper on antimicrobial activity of N. sativa in various germination stages against clinical strains.

Nigella sativa is an important spice and flavoring agent which is widely used in various European and Asian 
cuisines. It harbors an array of medicinal properties as shown by various researches. Germination is a 
phenomenon during which rapid changes in metabolic activities and</summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/6011918588146293793/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2013/02/antibacterial-activity-of-nigella.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/6011918588146293793'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/6011918588146293793'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2013/02/antibacterial-activity-of-nigella.html' title='Antibacterial activity of Nigella sativa seed in various  germination phases on clinical bacterial strains isolated  from human patients'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-277623595390698128</id><published>2012-12-26T22:01:00.001+05:30</published><updated>2012-12-26T22:01:20.378+05:30</updated><title type='text'>Bioethics in India</title><summary type="text">
 Knowledge, Attitudes and Practices of Bioethics among Doctors in a Tertiary Care Government Teaching Hospital in India
 J Clinic Res Bioeth 2011, 2:118. 0:0, (2011)
 http://dx.doi.org/10.4172/2155-9627.1000118

</summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/277623595390698128/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2012/12/bioethics-in-india.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/277623595390698128'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/277623595390698128'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2012/12/bioethics-in-india.html' title='Bioethics in India'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-6204211235423637626</id><published>2012-02-17T15:58:00.000+05:30</published><updated>2012-02-17T15:58:08.389+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="approval"/><category scheme="http://www.blogger.com/atom/ns#" term="banned drugs"/><category scheme="http://www.blogger.com/atom/ns#" term="drug information"/><category scheme="http://www.blogger.com/atom/ns#" term="drugs"/><category scheme="http://www.blogger.com/atom/ns#" term="FDA"/><category scheme="http://www.blogger.com/atom/ns#" term="new drugs"/><title type='text'>Drugs Update</title><summary type="text">

New drugs approved for
marketing in India during November-December 2011

Source:
http://cdsco.nic.in



 

  
  
Diazinon Flea Drops 

Spot on Dogs 30.0% w/w

  
  
For dogs infected with fleas.

 

  
  
Cabazitaxel Injection 

60mg / 1.5ml

  
  
In combination with prednisone for treatment of patients with
  hormone-refractory metastatic prostrate cancer previously treated with a
  </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/6204211235423637626/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2012/02/drugs-update.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/6204211235423637626'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/6204211235423637626'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2012/02/drugs-update.html' title='Drugs Update'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-3702370576360855077</id><published>2011-06-06T00:57:00.000+05:30</published><updated>2011-06-06T00:57:39.983+05:30</updated><title type='text'>Top News From American Heart Association (AHA) 2010 scientific sessions</title><summary type="text">The American Heart Association (AHA) 2010 Scientific Sessions took place in Chicago, Illinois, November 13-17, 2010.
Key trials presented at the sessions include:ADVANCE:&amp;nbsp;New LVAD equivalent to HeartMate II, nonrandomized study shows
RAFT: CRT shows survival benefit for patients with class 2 and 3 HF who have low EF and wide QRS
EMPHASIS-HF: Eplerenone shows large benefits in milder heart </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/3702370576360855077/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2011/06/top-news-from-american-heart.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/3702370576360855077'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/3702370576360855077'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2011/06/top-news-from-american-heart.html' title='Top News From American Heart Association (AHA) 2010 scientific sessions'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-2413392372473206297</id><published>2011-05-24T19:39:00.002+05:30</published><updated>2011-06-06T00:37:55.319+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Adverse effect"/><category scheme="http://www.blogger.com/atom/ns#" term="early fetal demise"/><category scheme="http://www.blogger.com/atom/ns#" term="misoprostol"/><category scheme="http://www.blogger.com/atom/ns#" term="oral route"/><category scheme="http://www.blogger.com/atom/ns#" term="sublingual route"/><title type='text'>Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise</title><summary type="text">
Background:&amp;nbsp;It has been established that sublingual (SL) route of misoprostol has a great potential to be developed for medical abortion, but there is dearth of evidence to reveal satisfaction rate and safety profile among patients of oral and SL routes. Thus, this study was conducted to provide an insight into the acceptability and safety profile of the same.
Materials and Methods:&amp;nbsp;A </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/2413392372473206297/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2011/05/acceptability-and-safety-profile-of.html#comment-form' title='3 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/2413392372473206297'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/2413392372473206297'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2011/05/acceptability-and-safety-profile-of.html' title='Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>3</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-2027012210980400356</id><published>2011-05-09T12:41:00.001+05:30</published><updated>2011-06-06T00:50:19.061+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Diabetes"/><category scheme="http://www.blogger.com/atom/ns#" term="Drug discovery and development"/><category scheme="http://www.blogger.com/atom/ns#" term="drug targets"/><category scheme="http://www.blogger.com/atom/ns#" term="new drugs"/><title type='text'>Promising Therapies in Diabetes Mellitus</title><summary type="text">Diabetes mellitus (DM) results from defects in insulin secretion (type 1) or insulin resistance (type 2). Insulin is used to manage type 1 DM, and oral hypoglycemic agents are used to manage type 2 DM. These therapies are inconsistent in maintaining glycemic control and cause some severe adverse effects such as undue weight gain and hypoglycemia. New and appropriate therapies are needed to </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/2027012210980400356/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2011/05/promising-therapies-in-diabetes.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/2027012210980400356'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/2027012210980400356'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2011/05/promising-therapies-in-diabetes.html' title='Promising Therapies in Diabetes Mellitus'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-305310503525736241</id><published>2011-03-10T00:25:00.000+05:30</published><updated>2011-03-10T00:25:10.963+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="BMI"/><category scheme="http://www.blogger.com/atom/ns#" term="fats"/><category scheme="http://www.blogger.com/atom/ns#" term="lifestyle"/><category scheme="http://www.blogger.com/atom/ns#" term="obesity"/><title type='text'>Measures of Obesity</title><summary type="text">There are several measures of obesity. Each &amp;nbsp;has its own strengths and limitations. The gold standard is dual-energy X-ray absorption (DEXA).&amp;nbsp;Body mass index (BMI) is calculated as mass (kg) per height2&amp;nbsp;(m2).&amp;nbsp;Waist circumference is widely thought to be a better indicator of cardiovascular risk than BMI, although some studies have shown them to be equally predictive. Other </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/305310503525736241/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2011/03/measures-of-obesity.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/305310503525736241'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/305310503525736241'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2011/03/measures-of-obesity.html' title='Measures of Obesity'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-3047764048609254063</id><published>2010-12-18T20:15:00.000+05:30</published><updated>2010-12-18T20:15:27.089+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Antibiotic resistance"/><category scheme="http://www.blogger.com/atom/ns#" term="Anticancer"/><category scheme="http://www.blogger.com/atom/ns#" term="antimicrobial"/><category scheme="http://www.blogger.com/atom/ns#" term="Antimicrobial activity"/><category scheme="http://www.blogger.com/atom/ns#" term="Drug discovery and development"/><category scheme="http://www.blogger.com/atom/ns#" term="drug information"/><category scheme="http://www.blogger.com/atom/ns#" term="drugs"/><category scheme="http://www.blogger.com/atom/ns#" term="infections"/><category scheme="http://www.blogger.com/atom/ns#" term="MCI"/><category scheme="http://www.blogger.com/atom/ns#" term="medical education"/><category scheme="http://www.blogger.com/atom/ns#" term="new drugs"/><category scheme="http://www.blogger.com/atom/ns#" term="pharma"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharma news"/><title type='text'>Top Ten Health Stories of the Year 2010</title><summary type="text">The year 2010 saw a lot of ‘hustle and bustle’ in the medical circle. Here are the Top 10 stories as viewed by eMedinewS.Overhauling of Medical Council of India:&amp;nbsp;The major story of the year was the arrest of MCI President Dr. Ketan Desai, dissolution of the MCI; appointment of six out of seven Board of Governors; subsequent release of Dr. Ketan Desai on bail, common entrance exam for MBBS; </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/3047764048609254063/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2010/12/top-ten-health-stories-of-year-2010.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/3047764048609254063'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/3047764048609254063'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2010/12/top-ten-health-stories-of-year-2010.html' title='Top Ten Health Stories of the Year 2010'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-7891956115103004125</id><published>2010-12-09T17:53:00.002+05:30</published><updated>2010-12-09T17:53:59.724+05:30</updated><title type='text'>Key findings from American Heart Association (AHA) 2010 scientific sessions</title><summary type="text">The American Heart Association (AHA) 2010 Scientific Sessions took place in Chicago, Illinois, November 13-17, 2010.
Key trials presented at the sessions include:ADVANCE:&amp;nbsp;New LVAD equivalent to HeartMate II, nonrandomized study shows
RAFT: CRT shows survival benefit for patients with class 2 and 3 HF who have low EF and wide QRS
EMPHASIS-HF: Eplerenone shows large benefits in milder heart </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/7891956115103004125/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2010/12/key-findings-from-american-heart.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/7891956115103004125'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/7891956115103004125'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2010/12/key-findings-from-american-heart.html' title='Key findings from American Heart Association (AHA) 2010 scientific sessions'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-4914484791364991337</id><published>2010-12-07T12:05:00.000+05:30</published><updated>2010-12-07T12:05:01.061+05:30</updated><title type='text'>Some drug interactions</title><summary type="text">Questioner: Edie
Question: My 85 year old mother has been taking some form of sleeping pills for  the past 50 years the last 20 years at least has been restoral she is  prescribed 30 mg. (there is times she binges and takes 2 pills a night)  She also takes Xanax, Tylenyol with Codeine. &amp;nbsp;Should someone her age (or  any age) be taking this much medication. &amp;nbsp;She has recently started  </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/4914484791364991337/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2010/12/some-drug-interactions.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/4914484791364991337'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/4914484791364991337'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2010/12/some-drug-interactions.html' title='Some drug interactions'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-2554736111088334596</id><published>2010-11-19T11:14:00.000+05:30</published><updated>2010-11-19T11:14:18.962+05:30</updated><title type='text'>Patient of prostatitis due to E.coli not responding to ciprofloxacin, levofloxacin and doxycycline</title><summary type="text">Questioner: Wong
Question-&amp;nbsp;I have been diagonsed with prostatitis. The offending organism is E.coli. I have been treated with Ciprofloxacin for 7 days and levofloxacin for 6 weeks with no improvement in symptoms. A later culture and sensitivity test showed that the bacteria is resistant to ciprofloxacin. Then I tried doxycycline for a month with no improvement. I asked my doctor to test </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/2554736111088334596/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2010/11/patient-of-prostatitis-due-to-ecoli-not.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/2554736111088334596'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/2554736111088334596'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2010/11/patient-of-prostatitis-due-to-ecoli-not.html' title='Patient of prostatitis due to E.coli not responding to ciprofloxacin, levofloxacin and doxycycline'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-8746268509902601821</id><published>2010-11-17T23:36:00.000+05:30</published><updated>2010-11-17T23:36:10.576+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Drug discovery and development"/><category scheme="http://www.blogger.com/atom/ns#" term="FDA"/><category scheme="http://www.blogger.com/atom/ns#" term="new drugs"/><category scheme="http://www.blogger.com/atom/ns#" term="pharma"/><category scheme="http://www.blogger.com/atom/ns#" term="Pharma news"/><title type='text'>New molecular entities (NMEs) approved in 2010</title><summary type="text">Asenapine (Saphris, Merck &amp;amp; Co., Inc.)
Bepotastine (Bepreve, ISTA Pharmaceuticals)
Dronedarone (Multaq, Sanofi-aventis)
Liraglutide (Victoza, Novo Nordisk)
Tocilizumab (Actemra, Genentech)
Ustekinumab (Stelara, Centocor Ortho Biotech)
For details see&amp;nbsp;http://www.medscape.com/viewarticle/731720
New Drug Review 2010Jack DeRuiter, PhD; Pamela L. Holston, RPh, BS, BAPosted: 11/10/2010; US </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/8746268509902601821/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2010/11/new-molecular-entities-nmes-approved-in.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/8746268509902601821'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/8746268509902601821'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2010/11/new-molecular-entities-nmes-approved-in.html' title='New molecular entities (NMEs) approved in 2010'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-6868474183794401933</id><published>2010-11-03T19:57:00.000+05:30</published><updated>2010-11-03T19:57:45.815+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Drug discovery and development"/><category scheme="http://www.blogger.com/atom/ns#" term="drug information"/><category scheme="http://www.blogger.com/atom/ns#" term="drugs"/><category scheme="http://www.blogger.com/atom/ns#" term="FDA"/><category scheme="http://www.blogger.com/atom/ns#" term="new drugs"/><title type='text'>Onabotulinumtoxin A for Migraine</title><summary type="text">The US Food and Drug Administration (FDA) has approved onabotulinumtoxinA (Botox;&amp;nbsp;Allergan Inc) for headache prophylaxis in patients with adult&amp;nbsp;chronic migraine&amp;nbsp;who&amp;nbsp;suffer headaches on 15 or more days per month, each lasting more than 4 hours.&amp;nbsp;&amp;nbsp;&amp;nbsp; To treat chronic migraine, onabotulinumtoxinA is given approximately every 12 weeks as multiple injections around the</summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/6868474183794401933/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2010/11/onabotulinumtoxin-for-migraine.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/6868474183794401933'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/6868474183794401933'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2010/11/onabotulinumtoxin-for-migraine.html' title='Onabotulinumtoxin A for Migraine'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-1218987918665646094</id><published>2010-11-02T15:25:00.000+05:30</published><updated>2010-11-02T15:25:38.427+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="academic research"/><category scheme="http://www.blogger.com/atom/ns#" term="clinical research"/><category scheme="http://www.blogger.com/atom/ns#" term="medical education"/><category scheme="http://www.blogger.com/atom/ns#" term="research"/><category scheme="http://www.blogger.com/atom/ns#" term="research  methodology"/><category scheme="http://www.blogger.com/atom/ns#" term="teaching"/><category scheme="http://www.blogger.com/atom/ns#" term="teaching methods"/><title type='text'>Which is more important for universities and colleges-Teaching or Research?</title><summary type="text">In universities here, research is the main criterion for appointment as well as promotion and&amp;nbsp; good researchers generally pay less attention to teaching. However, I feel one cannot remain abreast with recent developments in the field without being involved in research and the teaching will be very dogmatic. Also, only researchers can infuse a spirit of enquiry and innovation in their </summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/1218987918665646094/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2010/11/which-is-more-important-for.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/1218987918665646094'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/1218987918665646094'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2010/11/which-is-more-important-for.html' title='Which is more important for universities and colleges-Teaching or Research?'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-3368600154463886900.post-1892323952074230551</id><published>2010-10-31T08:23:00.000+05:30</published><updated>2010-10-31T08:23:22.916+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="antioxidants"/><category scheme="http://www.blogger.com/atom/ns#" term="fats"/><category scheme="http://www.blogger.com/atom/ns#" term="Fish"/><category scheme="http://www.blogger.com/atom/ns#" term="lifestyle"/><title type='text'>Fish oil: benefits versus harms</title><summary type="text">There are reports about prooxidant effects and aging accelerating effects of fish oils.&amp;nbsp;Whatever we ingest has benefits as well as harms and we have to weigh the two. In case of fish oil, the benefits far outweigh the harms. 0.5-1.8 g/day is the recommended dose for healthy people. Higher doses will be harmful. See http://healthyomega3.com/fish-oil-dosage/</summary><link rel='replies' type='application/atom+xml' href='http://medicalresearch.blogspot.com/feeds/1892323952074230551/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://medicalresearch.blogspot.com/2010/10/fish-oil-benefits-versus-harms.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/1892323952074230551'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/3368600154463886900/posts/default/1892323952074230551'/><link rel='alternate' type='text/html' href='http://medicalresearch.blogspot.com/2010/10/fish-oil-benefits-versus-harms.html' title='Fish oil: benefits versus harms'/><author><name>Dr. Mohammad Tariq Salman</name><uri>http://www.blogger.com/profile/18072398752683879869</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry></feed>